Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
56.96
+0.38 (0.67%)
At close: Mar 6, 2026
SHA:688050 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 363.9 | 536.66 | 354.9 | 472.87 |
Short-Term Investments | - | - | - | - | 480 |
Trading Asset Securities | - | 132.27 | 20.12 | 481.97 | 0.48 |
Cash & Short-Term Investments | 686.72 | 496.17 | 556.78 | 836.86 | 953.35 |
Cash Growth | 38.41% | -10.89% | -33.47% | -12.22% | -3.42% |
Accounts Receivable | - | 353.15 | 212.82 | 103.52 | 67.8 |
Other Receivables | - | 5.34 | 6.03 | 3.71 | 6.57 |
Receivables | - | 358.49 | 218.85 | 107.23 | 74.37 |
Inventory | - | 272.63 | 181.35 | 78.83 | 56.02 |
Prepaid Expenses | - | - | - | - | 0.15 |
Other Current Assets | - | 53.34 | 65.89 | 38.36 | 34.83 |
Total Current Assets | - | 1,181 | 1,023 | 1,061 | 1,119 |
Property, Plant & Equipment | - | 1,503 | 1,257 | 674.21 | 558.69 |
Long-Term Investments | - | 207.83 | 157.44 | 153.56 | 102.16 |
Goodwill | - | 139.11 | 132.6 | 21.13 | 21.13 |
Other Intangible Assets | - | 190.43 | 174.21 | 107.04 | 91.39 |
Long-Term Deferred Tax Assets | - | 72.89 | 46.74 | 29.91 | 34.35 |
Long-Term Deferred Charges | - | 149.56 | 105.72 | 60.83 | 67.49 |
Other Long-Term Assets | - | 36.85 | 149.43 | 120.81 | 45.49 |
Total Assets | - | 3,497 | 3,062 | 2,244 | 2,048 |
Accounts Payable | - | 56.08 | 49.05 | 13.86 | 5.57 |
Accrued Expenses | - | 55.74 | 50.87 | 42.59 | 31.82 |
Short-Term Debt | - | - | 25.55 | - | - |
Current Portion of Long-Term Debt | - | 80.83 | 92.39 | - | - |
Current Portion of Leases | - | 4.71 | - | - | - |
Current Income Taxes Payable | - | 3.77 | 2.31 | 13.5 | 6.99 |
Current Unearned Revenue | - | 11.46 | 12.6 | 6.47 | 6.16 |
Other Current Liabilities | - | 86.32 | 145 | 71.29 | 88.88 |
Total Current Liabilities | - | 298.91 | 377.77 | 147.71 | 139.42 |
Long-Term Debt | - | 513.13 | 287.44 | 149.77 | 143.37 |
Long-Term Leases | - | 10.23 | 13.85 | 13.02 | 11.48 |
Long-Term Unearned Revenue | - | 22.35 | 10.53 | 8.9 | 10.76 |
Long-Term Deferred Tax Liabilities | - | 16.26 | 15.14 | 4.26 | 0.8 |
Other Long-Term Liabilities | - | 1.82 | 1.13 | 0.64 | 1.63 |
Total Liabilities | - | 862.71 | 705.85 | 324.3 | 307.46 |
Common Stock | - | 189.54 | 105.25 | 105.18 | 105.14 |
Additional Paid-In Capital | - | 1,197 | 1,325 | 1,311 | 1,318 |
Retained Earnings | - | 1,037 | 699.81 | 444.01 | 250.23 |
Treasury Stock | - | -20.04 | - | - | - |
Comprehensive Income & Other | - | 6.33 | - | - | - |
Total Common Equity | 2,811 | 2,409 | 2,130 | 1,860 | 1,674 |
Minority Interest | - | 224.76 | 226.3 | 59.96 | 66.29 |
Shareholders' Equity | 3,008 | 2,634 | 2,356 | 1,920 | 1,740 |
Total Liabilities & Equity | - | 3,497 | 3,062 | 2,244 | 2,048 |
Total Debt | 639.21 | 608.9 | 419.23 | 162.79 | 154.85 |
Net Cash (Debt) | 47.51 | -112.73 | 137.55 | 674.07 | 798.5 |
Net Cash Growth | - | - | -79.59% | -15.58% | -19.11% |
Net Cash Per Share | 0.25 | -0.60 | 0.72 | 3.56 | 4.22 |
Filing Date Shares Outstanding | 192.85 | 189.54 | 189.45 | 189.32 | 189.25 |
Total Common Shares Outstanding | 192.85 | 189.54 | 189.45 | 189.32 | 189.25 |
Working Capital | - | 881.72 | 645.1 | 913.59 | 979.3 |
Book Value Per Share | 14.53 | 12.71 | 11.24 | 9.83 | 8.84 |
Tangible Book Value | 2,405 | 2,080 | 1,823 | 1,732 | 1,561 |
Tangible Book Value Per Share | 12.44 | 10.97 | 9.62 | 9.15 | 8.25 |
Buildings | - | 879.35 | 676.61 | 414.46 | 150.37 |
Machinery | - | 874.05 | 618.13 | 232.76 | 155.95 |
Construction In Progress | - | 52.88 | 154.26 | 120.6 | 318.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.